Zycubo Injection, Powder, Lyophilized, For Solution
Product Images NDC 42358-329

Product Visual Gallery

This gallery contains 45 technical images submitted to the FDA as part of the official labeling for Zycubo (NDC 42358-329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sentynl Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Zyc03 0002 01)

Chemical structure of copper histidinate, showing the molecular arrangement with copper (Cu) coordinated to histidine ligands.*

FDA Label Image

Figure 1 (Zyc03 0002 02)

A product-limit survival estimate chart showing survival probability over time in months for two groups, CuHis-ET and HC-ET. The graph includes censored data points marked with plus signs and shaded areas representing 95% confidence limits. The number of subjects at risk at various time points is indicated below the x-axis.*

FDA Label Image

Figure 2 (Zyc03 0002 03)

A product-limit survival estimates chart illustrating survival probability over time in months for two groups labeled CuHis-LT and HC-LT. The graph shows stepwise decreasing survival probability with censored data points marked. A shaded area represents 95% confidence limits, and the number of subjects at risk is annotated below the X-axis along the timeline.*

FDA Label Image

Figure (Zyc03 0002 04)

An instructional illustration showing a two-part image: on the left, a larger storage unit resembling a refrigerator with separate upper and lower compartments, and on the right, a smaller box labeled "ZYCUBO." An arrow points from the refrigerator to the Zycubo box, suggesting removal or transfer from storage to the product packaging.*

FDA Label Image

Figure (Zyc03 0002 05)

Illustration showing a vial labeled Zycubo alongside a clock indicating a 30-minute time period, suggesting a time-related instruction associated with the injection.*

FDA Label Image

Figure (Zyc03 0002 06)

Illustration showing a subcutaneous injection preparation set including a vial labeled 0.9% Sodium Chloride, two alcohol wipe packets, a cotton ball, and a gauze pad. The arrangement represents typical items used for injection site preparation and aftercare.*

FDA Label Image

Figure (Zyc03 0002 07)

An instructional diagram showing parts of two syringes used for Zycubo injection. The first is a 3 mL syringe with needle sizes 16 to 22 gauge, labeled with 'Preparing'. The second is a 1 mL syringe with a 23 to 27 gauge needle for injecting. A detailed diagram of the syringe shows parts including the needle, barrel, plunger, and plunger rod.*

FDA Label Image

Figure (Zyc03 0002 08)

An illustration of a sharps container used for the safe disposal of needles and other sharp medical instruments. The container is depicted as a closed, rectangular bin with a lid. The caption below reads 'Sharps container.'*

FDA Label Image

Figure (Zyc03 0002 09)

An instructional illustration showing hands being washed under a running faucet with water flowing. The image emphasizes hand hygiene, likely related to preparation or administration procedures for the drug.*

FDA Label Image

Figure (Zyc03 0002 10)

An instructional illustration demonstrating how to flip off caps from vials. The image shows a hand holding a vial labeled 'Zycubo' and another vial labeled '0.9% Sodium Chloride.' The action focuses on removing the protective caps from the vials prior to use.*

FDA Label Image

Figure (Zyc03 0002 11)

An instructional illustration showing a hand preparing an injection by withdrawing solution from a vial labeled Zycubo and another vial labeled sodium chloride. The inset highlights inserting a needle through a rubber stopper, indicating the preparation process for subcutaneous injection.*

FDA Label Image

Figure (Zyc03 0002 12)

An instructional illustration showing how to connect a syringe to a vial adapter for a 3 mL vial. The image demonstrates inserting the syringe plunger into the vial adapter, typically used for preparing an injection solution.*

FDA Label Image

Figure (Zyc03 0002 13)

Instructional illustration showing two hands preparing an injection by pulling apart a syringe and a vial or connector. This is likely guidance for assembling or handling the injection device for Zycubo (copper histidinate) lyophilized powder for solution.*

FDA Label Image

Figure (Zyc03 0002 14)

An instructional illustration showing a hand holding a syringe connected to a vial. The vial has a liquid level marked at 0.5 to 1 mL, indicating the measurement of solution to be drawn from the vial for subcutaneous injection.*

FDA Label Image

Figure (Zyc03 0002 15)

An instructional illustration showing the preparation step for an injection. One hand holds a vial labeled for injection, while the other hand inserts a syringe needle into the vial, accompanied by a downward arrow indicating insertion.*

FDA Label Image

Figure (Zyc03 0002 16)

An instructional illustration showing the preparation of a syringe and vial for injection. The vial is inverted and aligned with the syringe, demonstrating the step to draw liquid from the vial into the syringe.*

FDA Label Image

Figure (Zyc03 0002 17)

Illustration showing a person holding a vial upside down with one hand while withdrawing liquid into a syringe with the other hand. The image demonstrates preparation of an injectable solution from a vial, consistent with subcutaneous injection procedures.*

FDA Label Image

Figure (Zyc03 0002 18)

An instructional illustration showing the preparation of a syringe for injection. It depicts a hand holding a syringe and drawing liquid while highlighting the 1 mL mark on the syringe barrel for precise dosage measurement.*

FDA Label Image

Figure (Zyc03 0002 19)

An instructional illustration showing a hand holding a syringe and filling it from a vial. A close-up inset highlights the syringe plunger with visible measurement markings, emphasizing careful dosage measurement.*

FDA Label Image

Figure (Zyc03 0002 20)

An instructional illustration showing hands preparing a vial of medication for injection. One hand holds the vial upside down while the other hand inserts a needle into the vial, with a close-up inset highlighting the needle immersed in the solution inside the vial.*

FDA Label Image

Figure (Zyc03 0002 21)

An instructional diagram showing a person drawing 1 mL of liquid into a syringe from a vial, with a close-up inset emphasizing the syringe measurement markings at 0.5 mL and 1 mL. The image illustrates preparation of an injection dose, likely subcutaneous, consistent with the described product Zycubo copper histidinate injection powder for solution.*

FDA Label Image

Figure (Zyc03 0002 22)

An instructional illustration showing a hand holding a vial upside down while filling a syringe, indicating proper technique for drawing liquid from the vial by inserting the needle through the stopper with the vial inverted.*

FDA Label Image

Figure (Zyc03 0002 23)

An instructional illustration showing a person drawing a liquid from a vial into a syringe. One hand holds the vial steady while the other pulls back the syringe plunger to withdraw the liquid.*

FDA Label Image

Figure (Zyc03 0002 24)

The image shows a vial of Zycubo, a lyophilized powder for solution injection. The vial label prominently displays the brand name Zycubo. The vial is designed for subcutaneous administration, consistent with its use as a copper histidinate injection. The label and cap details are minimal but clear visually.*

FDA Label Image

Figure (Zyc03 0002 25)

An instructional illustration showing hands drawing liquid from a vial using a syringe, with an arrow indicating the action of pulling the syringe plunger upward. This demonstrates the preparation step for injection.*

FDA Label Image

Figure (Zyc03 0002 26)

An instructional illustration showing a sharps container with a syringe being disposed into it. The container is labeled "sharps container," indicating safe disposal of needles or syringes, relevant for injection drug use.*

FDA Label Image

Figure (Zyc03 0002 27)

An instructional illustration showing a hand holding a vial labeled Zycubo, with an arrow indicating a clockwise or twisting motion to open or rotate the vial. The vial is depicted with a blue label area and a cap on top.*

FDA Label Image

Figure (Zyc03 0002 28)

An instructional illustration showing a closed refrigerator next to a vial labeled ZYCUBO and a clock indicating 30 minutes. Below the images, the text instructs to remove the vial of mixed ZYCUBO solution from the refrigerator and wait 30 minutes before use.*

FDA Label Image

Figure (Zyc03 0002 29)

An instructional illustration showing water flowing from a faucet onto hands, demonstrating handwashing or hand rinsing technique.*

FDA Label Image

Figure (Zyc03 0002 30)

An instructional illustration showing a needle inserted through the rubber stopper of a vial, with a hand holding the vial. The image demonstrates the step of accessing the vial's contents, likely for a subcutaneous injection preparation.*

FDA Label Image

Figure (Zyc03 0002 31)

An instructional illustration showing a hand holding a vial labeled '1 mL' while drawing liquid into a syringe. The image demonstrates proper technique for withdrawing injection solution from a vial.*

FDA Label Image

Figure (Zyc03 0002 32)

An instructional illustration depicting two hands holding a syringe. The image shows arrows indicating pulling the syringe components apart, suggesting preparation or assembly steps for the syringe before use.*

FDA Label Image

Figure (Zyc03 0002 33)

An instructional illustration showing a pair of hands preparing an injection. One hand holds a vial labeled with a stopper, while the other hand inserts a syringe needle into the vial, indicating the withdrawal of medication for subcutaneous injection.*

FDA Label Image

Figure (Zyc03 0002 34)

An instructional illustration showing a vial labeled "Zycubo" connected via a needle to a syringe, demonstrating the process of drawing solution from the vial into the syringe for copper histidinate injection preparation.*

FDA Label Image

Figure (Zyc03 0002 35)

An instructional illustration showing a vial labeled Zycubo held upside down by one hand, with a syringe and needle inserted into the vial to draw the solution. A close-up inset highlights the needle immersed in the solution inside the vial. This diagram visually guides the preparation of Zycubo injection, powder, lyophilized, for solution.*

FDA Label Image

Figure (Zyc03 0002 36)

An instructional illustration showing the preparation of Zycubo injection. The image depicts a hand holding a vial and drawing 0.5 mL of solution into a syringe, with a close-up view of the syringe barrel highlighting the 0.5 mL mark for accurate dosing of copper histidinate injection, lyophilized powder for solution, subcutaneous use.*

FDA Label Image

Figure (Zyc03 0002 37)

An instructional illustration showing a hand holding a syringe with a zoomed-in view of the syringe barrel marked with volume measurements from 0.1 to 1.0 mL. The image demonstrates proper withdrawal or measurement of liquid medication using the syringe.*

FDA Label Image

Figure (Zyc03 0002 38)

An instructional illustration showing a hand holding a vial being drawn into a syringe. The syringe's measurement markings from 0.3 to 0.8 mL are visible, with an arrow indicating a 0.5 mL dosage. The image demonstrates how to measure a 0.5 mL volume for injection preparation.*

FDA Label Image

Figure (Zyc03 0002 39)

An instructional illustration depicting a hand holding an injection vial upside down. Below the vial, a syringe is being filled, with an arrow indicating the direction to pull the vial away from the syringe. This diagram likely demonstrates a step in preparing a subcutaneous injection.*

FDA Label Image

Figure (Zyc03 0002 40)

An instructional illustration showing the front and back views of a human figure with marked injection sites on the abdomen, thighs, and buttocks. The diagram advises rotating injection sites, indicating proper subcutaneous injection technique for an injectable drug.*

FDA Label Image

Figure (Zyc03 0002 41)

Illustration showing a hand using a small square wipe or swab, likely demonstrating the application of a cleaning or disinfecting wipe on a surface or skin. This instructional image may relate to preparation steps before administering an injection.*

FDA Label Image

Figure (Zyc03 0002 42)

Illustration showing the proper technique for subcutaneous injection, with a hand holding a syringe inserted at a 45-degree angle into the skin of another hand's finger.*

FDA Label Image

Figure (Zyc03 0002 43)

An instructional illustration showing a needle being placed into a sharps container, indicating safe disposal of the injection needle. The container is labeled 'Sharps container'.*

FDA Label Image

Principal Display Panel (2.9 mg Carton Label)

Zycubo 2.9 mg/vial (copper histidinate) injection powder lyophilized for solution, labeled for subcutaneous use. The carton displays the proprietary and generic names, strength, usage instructions, storage conditions, and manufacturer Sentynl Therapeutics, Inc. It includes barcode and NDC 42358-329-01.*

FDA Label Image

Principal Display Panel (2.9 mg Vial Label)

Label for Zycubo (copper histidinate) injection, 2.9 mg per vial. This single-dose vial is intended for subcutaneous use. The label includes storage instructions to keep unopened vials refrigerated at 2°C to 8°C. It specifies reconstitution with 1 mL sterile 0.9% Sodium Chloride Injection and notes the resulting concentration. Manufactured for Sentynl Therapeutics, Inc., Solana Beach, CA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.